Versant Capital Management’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$54.6K Sell
3,733
-123
-3% -$1.82K ﹤0.01% 1290
2026
Q1
$55.9K Buy
3,856
+306
+9% +$3.55K 0.01% 1163
2025
Q4
$34.1K Buy
3,550
+1,086
+44% +$10.4K ﹤0.01% 1309
2025
Q3
$23.2K Buy
2,464
+1,093
+80% +$10.4K ﹤0.01% 1506
2025
Q2
$14.5K Buy
1,371
+359
+35% +$4.53K ﹤0.01% 1698
2025
Q1
$15.2K Buy
1,012
+967
+2,149% +$16.1K ﹤0.01% 1494
2024
Q4
$741 Buy
45
+35
+350% +$690 ﹤0.01% 2237
2024
Q3
$247 Hold
10
﹤0.01% 1946
2024
Q2
$253 Hold
10
﹤0.01% 1876
2024
Q1
$254 Hold
10
﹤0.01% 1809
2023
Q4
$227 Sell
10
-96
-91% -$1.99K ﹤0.01% 1853
2023
Q3
$1.98K Sell
106
-453
-81% -$9.39K ﹤0.01% 1317
2023
Q2
$14.5K Hold
559
﹤0.01% 625
2023
Q1
$16K Sell
559
-11
-2% -$327 0.01% 573
2022
Q4
$16.9K Sell
570
-60
-10% -$1.71K 0.01% 513
2022
Q3
$15K Buy
630
+523
+489% +$12K 0.01% 501
2022
Q2
$2K Buy
107
+89
+494% +$1.99K ﹤0.01% 1060
2022
Q1
$0 Buy
+18
New +$549 ﹤0.01% 1447
2020
Q1
Sell
-211
Closed -$10K 1294
2019
Q4
$10K Hold
211
0.01% 685
2019
Q3
$11K Buy
211
+112
+113% +$5.75K 0.01% 663
2019
Q2
$4K Buy
99
+95
+2,375% +$3.46K ﹤0.01% 1000
2019
Q1
$0 Hold
4
﹤0.01% 1546
2018
Q4
$0 Hold
4
﹤0.01% 1462
2018
Q3
$0 Sell
4
-73
-95% -$2.88K ﹤0.01% 1507
2018
Q2
$2K Sell
77
-115
-60% -$4.74K ﹤0.01% 1274
2018
Q1
$9K Sell
192
-6
-3% -$339 ﹤0.01% 902
2017
Q4
$10K Sell
198
-20
-9% -$1.11K ﹤0.01% 902
2017
Q3
$12K Buy
218
+172
+374% +$8.99K 0.01% 759
2017
Q2
$2K Buy
+46
New +$2.12K ﹤0.01% 1223

Other funds holding ANIK